The FDA was petitioned to approve OTC switches for Allegra (fexofenadine), Allegra D 12-hour and 24-hour (fexofenadine with pseudophedrine), and Zyrtec (cetirizine) and Zyrtec D (cetirizine with pseudophedrine).